biotech investing | green leiter

Some highlights from ASX companies in the past month

Nimy Resources Ltd Positive news from diamond drill holes Nimy Resources announced some positive news from its fourth diamond drill hole...

1,067 views0 comments

Two leading Australian biotech companies working to solve global unmet needs

Antisense Therapeutics Limited (ASX: ANP; FSE: AWY) Antisense is an Australian publicly listed biotechnology company (with German...

Recce Pharmaceuticals Limited – A revolution in development of treating superbugs

Recce Pharmaceuticals (ASX: RCE: FSE: R9Q) is a global leader in the new generation of anti-infective therapies. The company is listed on...

A global biotech leader in synthetic anti-infectives dual lists in Germany

Recce Pharmaceuticals Ltd (ASX: RCE) and (FSE: R9Q) is pioneering a new class of synthetic anti-infectives to address the urgent global...

Antisense shares have increased by 60% after Sarepta results

Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...

1,000 views0 comments

mRNA and Antisense biotech - attracting the large fund managers and defining 2020

As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...

3,799 views0 comments

Broker upgrades Antisense Therapeutics by 470%

Australian based innovative biotech company, Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) received a strong brokers...

mRNA and RNA biotechnology – “The software of life”

The recent news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has increased...

1,572 views0 comments

Australian biotech companies becoming global players

Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...